Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Gross Margin (2020 - 2025)

RxSight's Gross Margin history spans 6 years, with the latest figure at 77.47% for Q4 2025.

  • For Q4 2025, Gross Margin rose 589.0% year-over-year to 77.47%; the TTM value through Dec 2025 reached 76.6%, up 589.0%, while the annual FY2025 figure was 76.6%, 589.0% up from the prior year.
  • Gross Margin reached 77.47% in Q4 2025 per RXST's latest filing, down from 79.85% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 79.85% in Q3 2025 to a low of 16.58% in Q2 2021.
  • Average Gross Margin over 5 years is 53.79%, with a median of 60.52% recorded in 2023.
  • Peak YoY movement for Gross Margin: skyrocketed 94bps in 2021, then surged 5873bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 34.05% in 2021, then surged by 35bps to 46.13% in 2022, then soared by 34bps to 61.77% in 2023, then grew by 16bps to 71.59% in 2024, then grew by 8bps to 77.47% in 2025.
  • Per Business Quant, the three most recent readings for RXST's Gross Margin are 77.47% (Q4 2025), 79.85% (Q3 2025), and 74.89% (Q2 2025).